知镜 Cognispect · 医学文献与研究工作台

How Patients with Atopic Dermatitis Experience Topical Therapy: A Real-World Analysis of Impact, Treatment Satisfaction, and HCP Communication.

Lio P, Burnette A, Hetzel A, Pierce EJ, Dawson Z, Fielding R, Haughton J, Weatherby S, Stein Gold L.
Dermatology and therapy · 2026-10-30 · PMID 42957861

文献摘要

Introduction Atopic dermatitis (AD) is a chronic, burdensome skin condition with significant impact on quality of life. Topical therapies are recommended as first-line treatment; however, patients with moderate-to-severe disease or inadequate disease control may require escalation to systemic therapy. Despite the central role of topical therapies in AD management, real-world data on treatment satisfaction and healthcare provider (HCP)-patient concordance remain limited. Methods This analysis draws on data from the Adelphi Real World Atopic Dermatitis Topical Plus Wave I Disease Specific Programme (DSP)™, a cross-sectional, real-world survey conducted in 2025 among 267 US adolescents and adults with current moderate-to-severe AD. Using linked surveys, we evaluated treatment satisfaction and communication dynamics between HCPs and patients/caregivers using topical therapies, both with and without advanced systemic therapy. Kappa analysis assessed HCP-patient/caregiver agreement. Results At time of survey completion, 233 participants had moderate AD (87%), as assessed by a HCP, with 34 participants (13%) having severe AD. Participants in both the topical medication only (TM) (n = 193; 72%) and topical plus advanced systemic therapy (TAS) (n = 74; 28%) groups reported day-to-day impacts on clothing choices, daily activities, and sleep. Notably, 68% of patients using topical therapies reported disliking how their topical therapy made their skin feel, underscoring a persistent daily treatment burden. Regarding satisfaction, moderate concordance between patient/caregiver and HCP ratings was observed among individuals receiving TM (κ = 0.57; p Conclusions These findings highlight persistent gaps in satisfaction and communication for patients with moderate-to-severe AD prescribed topical medications, underscoring the need for individualized treatment approaches. Addressing these gaps may help address unmet needs and inform more individualized care.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。